Acrylamide alters neurotransmitter induced calcium responses in murine ESC-derived and primary neurons

NeuroToxicology

Volumn 43, Issue , 2014, Pages 117-126

  Sisnaiske, Julia ^a   Hausherr, Vanessa ^a   Krug, Anne K ^b   Zimmer, Bastian ^b,c   Hengstler, Jan G ^a   Leist, Marcel ^b   van Thriel, Christoph ^a  

^a LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

3R; Acrylamide; Neuronal function; Neurotoxicity testing; Stem cell

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ACRYLAMIDE DERIVATIVE; BETA TUBULIN; CALCIUM; GLUTAMIC ACID; MICROTUBULE ASSOCIATED PROTEIN 2; NEURON SPECIFIC NUCLEAR PROTEIN; NEUROTRANSMITTER; PROTEIN; RBFOX3 PROTEIN; SYNAPTOPHYSIN; TAU PROTEIN; UNCLASSIFIED DRUG; ACRYLAMIDE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; NERVE PROTEIN; BETA TUBULIN III; CALCIUM ION; NESTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL TYPE; CONTROLLED STUDY; CRYOPRESERVATION; DEVELOPMENTAL TOXICITY; EMBRYO; EMBRYONIC STEM CELL; INCUBATION TIME; MOUSE; NERVE CELL; NEURITE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TOXICITY TESTING; ANIMAL; ANIMAL EMBRYO; BRAIN CORTEX; C57BL MOUSE; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; ACTION POTENTIAL; ANIMAL TISSUE; CALCIUM SIGNALING; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOTOXICITY TEST; IN VITRO STUDY; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NERVE FUNCTION; NEUROTRANSMISSION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

MURINAE;

ACRYLAMIDE; ANIMALS; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEURITES; NEURONS; NEUROTRANSMITTER AGENTS;

EID: 84905917087     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.03.010     Document Type: Article

References (64)

1. Agrawal A.K., Seth P.K., Squibb R.E., Tilson H.A., Uphouse L.L., Bondy S.C. Neurotransmitter receptors in brain regions of acrylamide-treated rats. I: Effects of a single exposure to acrylamide. Pharmacol Biochem Behav 1981, 14:527-531.
2. Bear M.F., Connors B.W., Paradiso M.A. Neurowissenschaften - Ein grundlegendes Lehrbuch für Biologie, Medizin und Psychologie 2008, Spektrum Akademischer Verlag, Berlin. 3rd ed.
3. Ben-Ari Y. Excitatory actions of gaba during development: the nature of the nurture. Nat Rev 2002, 3:728-739.
4. Bernhardt R., Matus A. Light and electron microscopic studies of the distribution of microtubule-associated protein 2 in rat brain: a difference between dendritic and axonal cytoskeletons. J Comp Neurol 1984, 226:203-221.
5. Binder L.I., Frankfurter A., Rebhun L.I. The distribution of tau in the mammalian central nervous system. J Cell Biol 1985, 101:1371-1378.
6. Bondy S.C., Tilson H.A., Agrawal A.K. Neurotransmitter receptors in brain regions of acrylamide-treated rats. II: Effects of extended exposure to acrylamide. Pharmacol Biochem Behav 1981, 14:533-537.
7. Brustle O. Developmental neuroscience: miniature human brains. Nature 2013, 501:319-320.
8. Collins F.S., Gray G.M., Toxicology Bucher J.R. Transforming environmental health protection. Science 2008, 319:906-907.
9. Crofton K.M., Padilla S., Tilson H.A., Anthony D.C., Raymer J.H., MacPhail R.C. The impact of dose rate on the neurotoxicity of acrylamide: the interaction of administered dose, target tissue concentrations, tissue damage, and functional effects. Toxicol Appl Pharmacol 1996, 139:163-176.
10. Defranchi E., Novellino A., Whelan M., Vogel S., Ramirez T., van Ravenzwaay B., et al. Feasibility assessment of micro-electrode chip assay as a method of detecting neurotoxicity in vitro. Front Neuroeng 2011, 4:6.
11. Dinh N.D., Chiang Y.Y., Hardelauf H., Baumann J., Jackson E., Waide S., et al. Microfluidic construction of minimalistic neuronal co-cultures. Lab Chip 2013, 13:1402-1412.
12. Dotti C.G., Banker G.A., Binder L.I. The expression and distribution of the microtubule-associated proteins tau and microtubule-associated protein 2 in hippocampal neurons in the rat in situ and in cell culture. Neuroscience 1987, 23:121-130.
13. Friedman M. Chemistry, biochemistry, and safety of acrylamide. A review. J Agric Food Chem 2003, 51:4504-4526.
14. Fritsche E., Cline J.E., Nguyen N.H., Scanlan T.S., Abel J. Polychlorinated biphenyls disturb differentiation of normal human neural progenitor cells: clue for involvement of thyroid hormone receptors. Environ Health Perspect 2005, 113:871-876.
15. Gassmann K., Abel J., Bothe H., Haarmann-Stemmann T., Merk H.F., Quasthoff K.N., et al. Species-specific differential AhR expression protects human neural progenitor cells against developmental neurotoxicity of PAHs. Environ Health Perspect 2010, 118:1571-1577.
16. Goffeng L.O., Heier M.S., Kjuus H., Sjoholm H., Sorensen K.A., Skaug V. Nerve conduction, visual evoked responses and electroretinography in tunnel workers previously exposed to acrylamide and N-methylolacrylamide containing grouting agents. Neurotoxicol Teratol 2008, 30:186-194.
17. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260:3440-3450.
18. Hardelauf H., Sisnaiske J., Taghipour-Anvari A.A., Jacob P., Drabiniok E., Marggraf U., et al. High fidelity neuronal networks formed by plasma masking with a bilayer membrane: analysis of neurodegenerative and neuroprotective processes. Lab Chip 2011, 11:2763-2771.
19. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 1994, 17:31-108.
20. Howard A.S., Bucelli R., Jett D.A., Bruun D., Yang D., Lein P.J. Chlorpyrifos exerts opposing effects on axonal and dendritic growth in primary neuronal cultures. Toxicol Appl Pharmacol 2005, 207:112-124.
21. Huang F., Schneider J.S. Effects of lead exposure on proliferation and differentiation of neural stem cells derived from different regions of embryonic rat brain. Neurotoxicology 2004, 25:1001-1012.
22. Kadereit S., Zimmer B., van Thriel C., Hengstler J.G., Leist M. Compound selection for in vitro modeling of developmental neurotoxicity. Front Biosci (Landmark Ed) 2012, 17:2442-2460.
23. Kandel E.R., Schwartz J.C., Jessell T.M. Principles of neural science 2000, Mcgraw-Hill Professional, New York. 4th ed.
24. Klemm M., Schrattenholz A. Neurotoxicity of active compounds - establishment of hESC-lines and proteomics technologies for human embryo- and neurotoxicity screening and biomarker identification. ALTEX 2004, 21(Suppl. 3):41-48.
25. Kosik K.S., Finch E.A. MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum. J Neurosci 1987, 7:3142-3153.
26. Krug A.K., Balmer N.V., Matt F., Schonenberger F., Merhof D., Leist M. Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants. Arch Toxicol 2013, 87:2215-2231.
27. Krug A.K., Kolde R., Gaspar J.A., Rempel E., Balmer N.V., Meganathan K., et al. Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol 2013, 87:123-143.
28. Lancaster M.A., Renner M., Martin C.A., Wenzel D., Bicknell L.S., Hurles M.E., et al. Cerebral organoids model human brain development and microcephaly. Nature 2013, 501:373-379.
29. Lappe-Siefke C., Loebrich S., Hevers W., Waidmann O.B., Schweizer M., Fehr S., et al. The ataxia (axJ) mutation causes abnormal GABAA receptor turnover in mice. PLoS Genet 2009, 5:e1000631.
30. Leist M., Bremer S., Brundin P., Hescheler J., Kirkeby A., Krause K.H., et al. The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. ALTEX 2008, 25:163-190.
31. Leist M., Hartung T., Nicotera P. The dawning of a new age of toxicology. ALTEX 2008, 25:103-114.
32. LoPachin R.M., Barber D.S. Synaptic cysteine sulfhydryl groups as targets of electrophilic neurotoxicants. Toxicol Sci 2006, 94:240-255.
33. LoPachin R.M., Gavin T. Molecular mechanism of acrylamide neurotoxicity: lessons learned from organic chemistry. Environ Health Perspect 2012, 120:1650-1657.
34. LoPachin R.M., Schwarcz A.I., Gaughan C.L., Mansukhani S., Das S. In vivo and in vitro effects of acrylamide on synaptosomal neurotransmitter uptake and release. Neurotoxicology 2004, 25:349-363.
35. LoTurco J.J., Owens D.F., Heath M.J., Davis M.B., Kriegstein A.R. GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 1995, 15:1287-1298.
36. Mandell J.W., Banker G.A. The microtubule cytoskeleton and the development of neuronal polarity. Neurobiol Aging 1995, 16:229-237. discussion 38.
37. Maricq A.V., Peterson A.S., Brake A.J., Myers R.M., Julius D. Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 1991, 254:432-437.
38. Martenson C.H., Sheetz M.P., Graham D.G. In vitro acrylamide exposure alters growth cone morphology. Toxicol Appl Pharmacol 1995, 131:119-129.
39. Matus A. Microtubule-associated proteins and the determination of neuronal form. J Physiol (Paris) 1990, 84:134-137.
40. Mullen R.J., Buck C.R., Smith A.M. NeuN, a neuronal specific nuclear protein in vertebrates. Development 1992, 116:201-211.
41. Nichols D.E., Nichols C.D. Serotonin receptors. Chem Rev 2008, 108:1614-1641.
42. Nordin-Andersson M., Forsby A., Heldring N., Dejongh J., Kjellstrand P., Walum E. Neurite degeneration in differentiated human neuroblastoma cells. Toxicol In Vitro 1998, 12:557-560.
43. Nordin-Andersson M., Walum E., Kjellstrand P., Forsby A. Acrylamide-induced effects on general and neurospecific cellular functions during exposure and recovery. Cell Biol Toxicol 2003, 19:43-51.
44. Rehm H., Wiedenmann B., Betz H. Molecular characterization of synaptophysin, a major calcium-binding protein of the synaptic vesicle membrane. EMBO J 1986, 5:535-541.
45. Rohlman D.S., Lucchini R., Anger W.K., Bellinger D.C., van Thriel C. Neurobehavioral testing in human risk assessment. Neurotoxicology 2008, 29:555-566.
46. Schmidt-Kastner R., Humpel C. Nestin expression persists in astrocytes of organotypic slice cultures from rat cortex. Int J Dev Neurosci 2002, 20:29-38.
47. Schmuck G., Schluter G. An in vitro model for toxicological investigations of environmental neurotoxins in primary neuronal cell cultures. Toxicol Ind Health 1996, 12:683-696.
48. Shi J., Ma Y., Zheng M., Ruan Z., Liu J., Tian S., et al. Effect of sub-acute exposure to acrylamide on GABAergic neurons and astrocytes in weaning rat cerebellum. Toxicol Ind Health 2012, 28:10-20.
49. Spencer P.S., Schaumburg H.H. Nervous system degeneration produced by acrylamide monomer. Environ Health Perspect 1975, 11:129-133.
50. Stett A., Egert U., Guenther E., Hofmann F., Meyer T., Nisch W., et al. Biological application of microelectrode arrays in drug discovery and basic research. Anal Bioanal Chem 2003, 377:486-495.
51. Stiegler N.V., Krug A.K., Matt F., Leist M. Assessment of chemical-induced impairment of human neurite outgrowth by multiparametric live cell imaging in high-density cultures. Toxicol Sci 2011, 121:73-87.
52. Suzuki K., Pfaff L.D. Acrylamide neuropathy in rats. An electron microscopic study of degeneration and regeneration. Acta Neuropathol 1973, 24:197-213.
53. Tamm C., Duckworth J., Hermanson O., Ceccatelli S. High susceptibility of neural stem cells to methylmercury toxicity: effects on cell survival and neuronal differentiation. J Neurochem 2006, 97:69-78.
54. Tareke E., Rydberg P., Karlsson P., Eriksson S., Tornqvist M. Acrylamide: a cooking carcinogen. Chem Res Toxicol 2000, 13:517-522.
55. Tateno M., Ukai W., Ozawa H., Yamamoto M., Toki S., Ikeda H., et al. Ethanol inhibition of neural stem cell differentiation is reduced by neurotrophic factors. Alcohol Clin Exp Res 2004, 28. 134S-8S.
56. Undie A.S., Friedman E. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 1990, 253:987-992.
57. van Thriel C., Westerink R.H., Beste C., Bale A.S., Lein P.J., Leist M. Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts. Neurotoxicology 2012, 33:911-924.
58. van Vliet E., Stoppini L., Balestrino M., Eskes C., Griesinger C., Sobanski T., et al. Electrophysiological recording of re-aggregating brain cell cultures on multi-electrode arrays to detect acute neurotoxic effects. Neurotoxicology 2007, 28:1136-1146.
59. Visan A., Hayess K., Sittner D., Pohl E.E., Riebeling C., Slawik B., et al. Neural differentiation of mouse embryonic stem cells as a tool to assess developmental neurotoxicity in vitro. Neurotoxicology 2012, 33:1135-1146.
60. Wiedenmann B., Franke W.W. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 1985, 41:1017-1028.
61. Ying Q.L., Smith A.G. Defined conditions for neural commitment and differentiation. Methods Enzymol 2003, 365:327-341.
62. Zeng X., Chen J., Deng X., Liu Y., Rao M.S., Cadet J.L., et al. An in vitro model of human dopaminergic neurons derived from embryonic stem cells: MPP+ toxicity and GDNF neuroprotection. Neuropsychopharmacology 2006, 31:2708-2715.
63. Zimmer B., Kuegler P.B., Baudis B., Genewsky A., Tanavde V., Koh W., et al. Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing. Cell Death Differ 2011, 18:383-395.
64. Zimmer B., Lee G., Balmer N.V., Meganathan K., Sachinidis A., Studer L., et al. Evaluation of developmental toxicants and signaling pathways in a functional test based on the migration of human neural crest cells. Environ Health Perspect 2012, 120:1116-1122.